middle.news
Botanix Grows Sofdra Prescriptions Amid $45M Capital Raise and New API Supplier
9:16am on Wednesday 29th of April, 2026 AEST
•
Healthcare
Read Story
Botanix Grows Sofdra Prescriptions Amid $45M Capital Raise and New API Supplier
9:16am on Wednesday 29th of April, 2026 AEST
Key Points
5% increase in Sofdra prescriptions shipped
Net revenue down due to annual deductible reset
$45 million capital raising completed
API supply agreement renegotiated to defer payments
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Botanix Pharmaceuticals (ASX:BOT)
OPEN ARTICLE